Crinetics Pharmaceuticals (CRNX) Net Margin Growth (1y) (2018 - 2026)
Crinetics Pharmaceuticals (CRNX) Net Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn | 447.00 |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn | 2,072.00 |
| 10 | Crinetics Pharmaceuticals | 8.72 Bn | 7.43 Bn | 10.53 Mn | -2.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.91 Mn |
| Jun 30, 2025 | -734,415.00 |
| Mar 31, 2025 | 1.64 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 866,750.00 |
| Sep 30, 2023 | 716,428.00 |
| Jun 30, 2023 | -449,280.00 |
| Mar 31, 2023 | 64,319.00 |
| Dec 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | -4.82 Mn |
| Dec 31, 2020 | 3.57 Mn |
| Mar 31, 2020 | -3.82 Mn |
| Dec 31, 2019 | -193,896.00 |
| Sep 30, 2019 | 400,906.00 |
| Mar 31, 2019 | -1.19 Mn |
| Dec 31, 2018 | -220,819.00 |
| Sep 30, 2018 | -1.05 Mn |
| Jun 30, 2018 | -296,267.00 |